Berkshire Biomedical announced today that it appointed John E. Timberlake as its new president and CEO. Dallas-based Berkshire Biomedical, which develops a virtual care prescription drug delivery and management system, also added Timberlake to its advisory board, according to a news release. The COPA system is designed to offer virtual care delivery using technology combined […]
